Laboratory of Immunology, Faculty of Pharmacy, Osaka Ohtani University, Osaka, Tondabayashi, Japan;
Japan Society for the Promotion of Science, Tokyo, Japan.
J Immunol. 2021 Aug 1;207(3):771-776. doi: 10.4049/jimmunol.2001083. Epub 2021 Jul 21.
Tumor-infiltrating regulatory T cells (Tregs) have been extensively studied as therapeutic targets. However, not all infiltrating T cells exert their functions equally, presumably because of their heterogeneity and substantial turnover in tissues. In this study, we hypothesized that intertissue migration underlies the functional heterogeneity of Tregs. To test this, we applied in vivo photolabeling to examine single-cell diversity of immunosuppressive molecules in mouse Tregs migrating to, remaining in, and emigrating from MC38 tumors. Neuropilin-1 (Nrp1) expression was inversely correlated with that of six other molecules associated with Treg function. Unsupervised clustering analyses revealed that clusters containing Tregs that were retained in tumors expressed high levels of the six functional molecules but not of Nrp1. However, these clusters represented only half of the Tregs migrating to the tumor, suggesting evolving heterogeneity of tumor-infiltrating Tregs. Thus, we propose progressive pathways of Treg activation and migration between tumors and draining lymph nodes.
肿瘤浸润调节性 T 细胞(Tregs)已被广泛研究作为治疗靶点。然而,并非所有浸润的 T 细胞都能同等地发挥其功能,这可能是由于它们在组织中的异质性和大量更新。在这项研究中,我们假设组织间迁移是 Tregs 功能异质性的基础。为了验证这一点,我们应用体内光标记来检测迁移到、停留在和从 MC38 肿瘤中迁出的小鼠 Tregs 中抑制性分子的单细胞多样性。神经纤毛蛋白-1(Nrp1)的表达与其他六个与 Treg 功能相关的分子呈负相关。无监督聚类分析显示,含有在肿瘤中被保留的 Tregs 的簇表达高水平的六个功能分子,但不表达 Nrp1。然而,这些簇只代表了迁移到肿瘤的 Tregs 的一半,这表明肿瘤浸润 Tregs 的异质性不断演变。因此,我们提出了 Treg 在肿瘤和引流淋巴结之间的激活和迁移的渐进途径。